Potential usefulness of sevelamer hydrochloride to improve cardiac outcome in patients with coronary disease and normal renal function.
Di Vito
Clara
C
Bruno
Anna
A
Emanuele
Enzo
E
D002614:Chelating Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007668:Kidney / Q000502:physiology*; D008955:Models, Cardiovascular; D010710:Phosphates / Q000097:blood*; D011073:Polyamines / Q000009:adverse effects / Q000627:therapeutic use*; D000069603:Sevelamer; D016896:Treatment Outcome
D002614:Chelating Agents; D010710:Phosphates; D011073:Polyamines; D000069603:Sevelamer